Novartis Pharmaceuticals has used its patented hydrosol formulation to administer the poorly soluble immunosuppressant drug cyclosporin in a readily absorbable aqueous form. Novartis's US patent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results